312 related articles for article (PubMed ID: 22761567)
1. Modeling within-host dynamics of influenza virus infection including immune responses.
Pawelek KA; Huynh GT; Quinlivan M; Cullinane A; Rong L; Perelson AS
PLoS Comput Biol; 2012; 8(6):e1002588. PubMed ID: 22761567
[TBL] [Abstract][Full Text] [Related]
2. Dynamics of influenza virus infection and pathology.
Saenz RA; Quinlivan M; Elton D; Macrae S; Blunden AS; Mumford JA; Daly JM; Digard P; Cullinane A; Grenfell BT; McCauley JW; Wood JL; Gog JR
J Virol; 2010 Apr; 84(8):3974-83. PubMed ID: 20130053
[TBL] [Abstract][Full Text] [Related]
3. Innate Immunity and the Inter-exposure Interval Determine the Dynamics of Secondary Influenza Virus Infection and Explain Observed Viral Hierarchies.
Cao P; Yan AW; Heffernan JM; Petrie S; Moss RG; Carolan LA; Guarnaccia TA; Kelso A; Barr IG; McVernon J; Laurie KL; McCaw JM
PLoS Comput Biol; 2015 Aug; 11(8):e1004334. PubMed ID: 26284917
[TBL] [Abstract][Full Text] [Related]
4. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
Paillot R; Grimmett H; Elton D; Daly JM
Vet Res; 2008; 39(3):21. PubMed ID: 18252187
[TBL] [Abstract][Full Text] [Related]
5. Antibody and IFN-gamma responses induced by a recombinant canarypox vaccine and challenge infection with equine influenza virus.
Paillot R; Kydd JH; Sindle T; Hannant D; Edlund Toulemonde C; Audonnet JC; Minke JM; Daly JM
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):225-33. PubMed ID: 16621023
[TBL] [Abstract][Full Text] [Related]
6. Discrete Dynamical Modeling of Influenza Virus Infection Suggests Age-Dependent Differences in Immunity.
Keef E; Zhang LA; Swigon D; Urbano A; Ermentrout GB; Matuszewski M; Toapanta FR; Ross TM; Parker RS; Clermont G
J Virol; 2017 Dec; 91(23):. PubMed ID: 28904202
[TBL] [Abstract][Full Text] [Related]
7. New assays to measure equine influenza virus-specific Type 1 immunity in horses.
Paillot R; Kydd JH; MacRae S; Minke JM; Hannant D; Daly JM
Vaccine; 2007 Oct; 25(42):7385-98. PubMed ID: 17881098
[TBL] [Abstract][Full Text] [Related]
8. Antigenic evolution of viruses in host populations.
Rouzine IM; Rozhnova G
PLoS Pathog; 2018 Sep; 14(9):e1007291. PubMed ID: 30208108
[TBL] [Abstract][Full Text] [Related]
9. Quantifying the impact of immune escape on transmission dynamics of influenza.
Park AW; Daly JM; Lewis NS; Smith DJ; Wood JL; Grenfell BT
Science; 2009 Oct; 326(5953):726-8. PubMed ID: 19900931
[TBL] [Abstract][Full Text] [Related]
10. Inefficient transmissibility of NS-truncated H3N8 equine influenza virus in dogs.
Na W; Song M; Yeom M; Park N; Kang B; Moon H; Jeong DG; Kim JK; Song D
J Microbiol Biotechnol; 2015 Mar; 25(3):317-20. PubMed ID: 25315051
[TBL] [Abstract][Full Text] [Related]
11. Onset and duration of immunity to equine influenza virus resulting from canarypox-vectored (ALVAC) vaccination.
Soboll G; Hussey SB; Minke JM; Landolt GA; Hunter JS; Jagannatha S; Lunn DP
Vet Immunol Immunopathol; 2010 May; 135(1-2):100-107. PubMed ID: 20018384
[TBL] [Abstract][Full Text] [Related]
12. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
[TBL] [Abstract][Full Text] [Related]
13. A naturally truncated NS1 protein of influenza A virus impairs its interferon-antagonizing activity and thereby confers attenuation in vitro.
Lee J; Park JH; Min JY
Arch Virol; 2017 Jan; 162(1):13-21. PubMed ID: 27400993
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
Minke JM; Toulemonde CE; Coupier H; Guigal PM; Dinic S; Sindle T; Jessett D; Black L; Bublot M; Pardo MC; Audonnet JC
Am J Vet Res; 2007 Feb; 68(2):213-9. PubMed ID: 17269889
[TBL] [Abstract][Full Text] [Related]
15. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus.
Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ
Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689
[TBL] [Abstract][Full Text] [Related]
16. Little evidence of human infection with equine influenza during the 2007 epizootic, Queensland, Australia.
Burnell FJ; Holmes MA; Roiko AH; Lowe JB; Heil GL; White SK; Gray GC
J Clin Virol; 2014 Feb; 59(2):100-3. PubMed ID: 24360918
[TBL] [Abstract][Full Text] [Related]
17. A Brief Introduction to Equine Influenza and Equine Influenza Viruses.
Chambers TM
Methods Mol Biol; 2020; 2123():355-360. PubMed ID: 32170701
[TBL] [Abstract][Full Text] [Related]
18. Assessment of antigenic difference of equine influenza virus strains by challenge study in horses.
Yamanaka T; Nemoto M; Bannai H; Tsujimura K; Kondo T; Matsumura T; Gildea S; Cullinane A
Influenza Other Respir Viruses; 2016 Nov; 10(6):536-539. PubMed ID: 27465864
[TBL] [Abstract][Full Text] [Related]
19. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
